Category Archives: Recent News

BriaCell Therapeutics Corp. to Clarify Record Date
October 1, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, October 1, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

Note from Chairman of BriaCell Therapeutics – October is Breast Cancer Awareness Month
October 1, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, October 1, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Appoints Immunology Expert, Dr. Cara L. Haymaker, to Scientific Advisory Board; BriaCell CEO to Lead Special ‘Targeted Immunotherapy’ Issue in Prestigious Journals
September 25, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, September 25, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Private Placement of up to $600,000
September 20, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, September 20, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Public Disclosure: Remarkable Responder in Combination Study of Lead Candidate with KEYTRUDA®
September 19, 2019

Material information is being presented concurrent with this press release at 9:35am Eastern Time at ...

BriaCell to Present September 19th at 2nd Annual Next Gen Immuno-Oncology Congress in Philadelphia
September 16, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, September 16, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Closing of Upsized Non-Brokered Private Placement of $846,301.49
September 9, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, September 9, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Participation at the 21st Annual Global Investment Conference in New York City September 8-10, 2019
August 27, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, August 27, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Appoints Richard J. Berman to Board of Directors
August 12, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, August 12, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces $350,000 Equity Investment by Board of Directors
July 23, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, July 23, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

Skip to content